Skip to content
What's on

Transforming UK translation conference

Conference

Location

The Royal Society, London, 6-9 Carlton House Terrace, London, SW1Y 5AG

Overview

Image credit: Ales-A

Building on previous work of the Royal Society, this conference will focus on current challenges surrounding translation of research into successful business outcomes and how we can overcome them.

The meeting will consist of a mixture of talks and round table discussions, and bring together key stakeholders across the innovation continuum to discuss some of the key challenges, best practice and ways we can foster stronger industry-academia relationships.

Details about the speakers and discussions will be available closer to the event. 

Attending this event

  • Please note this conference is free (lunch and refreshments included) but by invitation only. You will require an invitation in order to register. To request an invitation or for more information, please contact the Industry team
  • Travel and accessibility information

Schedule of talks

31 October

09:00-09:30

Registration and refreshments

09:30-09:45

Opening remarks

1 talk Show detail Hide detail

Dame Sue Ion FREng FRS, Chair of the Royal Society Science, Industry and Translation Committee

Show speakers

09:45-10:30

Plenary session

3 talks Show detail Hide detail

09:45-10:00

Dr Stephen Cook, Chief Commercial Officer, Technology Group, BP

Show speakers

10:00-10:15

Peter Brewin, Director, Concrete Canvas

Show speakers

10:15-10:30

Dr Celia Caulcott, Vice-Provost (Enterprise), UCL

Show speakers

10:30-13:00

Industry-academia engagement

3 talks Show detail Hide detail

Chairs

Dr David Bembo, Director of Research & Innovation Services, Cardiff University

10:35-10:50 Keynote: Industry-university strategic partnerships

Dr Matt Reid, Strategy Senior Open Innovation Director, Unilever

Show speakers

10:50-11:20 Panel: How do universities interface better with industry and how do you turn initial interactions into something meaningful?

Dr John Patterson
Kate Barnard, Engineering Programme Manager, University Research, Rolls-Royce
Patrick Speedie, Co-Founder & Director, IN-PART

Show speakers

11:20-13:00 Workshop

13:00-13:45

Lunch

13:45-16:15

Partnerships: creating value for both sides

3 talks Show detail Hide detail

13:50-14:05 Keynote

Dr Malcolm Skingle CBE, GSK

Show speakers

14:05-14:35 Panel: Value proposition on both sides of the partnership, and clarity on the challenges and potential channels of exploitation

Anne Muir, Acting Head of Business Engagement & Commercialisation, University of Dundee
Dr Darren Budd, Commercial Director (UK & Ireland), BASF

Show speakers

14:35-16:15 Workshop

16:15-16:35

Afternoon refreshments

16:35-17:20

Case studies: attracting, training and retaining the right talent

4 talks Show detail Hide detail

16:40-16:50

Dr Georgia Gliki, Senior Business Manager, LifeArc

Show speakers

16:50-17:00

James Otter, Ellipson Ltd, Entrepreneur in Residence at the University of Southampton, UK

Show speakers

17:00-17:10 Community Building, Fundamental Research and Translation in Synthetic Biology at Bristol

Professor Dek Woolfosn, Professor of Chemistry and Biochemistry; Principal Investigator of BrisSynbio; Director of the Bristol BioDesign Institute, University of Bristol

Abstract

BrisSynBio is one of six BBSRC/EPSRC-funded Synthetic Biology Research Centres established in 2014/15 to nucleate research in synthetic biology across the UK, and to facilitate translating this research. BrisSynBio’s science focuses on fundamental aspects of biomolecular design and engineering and applying these to advance synthetic biology.  BrisSynBio created the new post of BrisSynBio Innovation Manager to encourage and oversee the translation of this basic synthetic-biology research into real-life applications in drug discovery, new vaccine platforms, designing novel biomaterials, and biosensor development. To date, this has resulted in four new synthetic biology-based companies, 5 new patent applications, and securing £4.5M of translational funding. In addition, interactions with GSK have led to the award of a Royal Society Entrepreneur in Residence, Dr David Tew, who spends part of his time in Bristol on BrisSynBio’s Innovation Programme. The University has recognised these successes by establishing the Bristol BioDesign Institute.

Show speakers

17:10-17:25 Innovation and commercialisation for UK PLC

Professor Andrew Hopper CBE FREng FRS, University of Cambridge

Show speakers

17:20-17:35

Summary and closing remarks

17:35-19:00

Drinks reception

Transforming UK translation conference

This conference will highlight examples of best practise of research translation and commercialisation in the UK.

The Royal Society, London 6-9 Carlton House Terrace London SW1Y 5AG UK
Was this page useful?
Thank you for your feedback
Thank you for your feedback. Please help us improve this page by taking our short survey.